Published in JAMA on February 23, 2000
Adrenal Function in Critical Illness | NCT00156767
Bovine Intestinal Alkaline Phosphatase for the Treatment of Patients With Sepsis | NCT00430859
Reduced cortisol metabolism during critical illness. N Engl J Med (2013) 6.01
Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ (2004) 2.39
ACTH and cortisol response to critical illness in term and late preterm newborns. J Perinatol (2008) 2.24
The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med (2005) 1.75
Intensive insulin in intensive care. N Engl J Med (2006) 1.68
Dynamic pituitary-adrenal interactions in response to cardiac surgery. Crit Care Med (2015) 1.64
Reducing mortality in sepsis: new directions. Crit Care (2002) 1.52
Diminished adrenal sensitivity to endogenous and exogenous adrenocorticotropic hormone in critical illness: a prospective cohort study. Crit Care (2015) 1.46
Suppression of Dendritic Cell-Derived IL-12 by Endogenous Glucocorticoids Is Protective in LPS-Induced Sepsis. PLoS Biol (2015) 1.40
Design and conduct of the activated protein C and corticosteroids for human septic shock (APROCCHSS) trial. Ann Intensive Care (2016) 1.39
Physiological-dose steroid therapy in sepsis [ISRCTN36253388]. Crit Care (2002) 1.24
Pediatric sepsis: challenges and adjunctive therapies. Crit Care Clin (2013) 1.19
Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock. Crit Care (2007) 1.15
Science review: The brain in sepsis--culprit and victim. Crit Care (2004) 1.11
Clinical review: corticotherapy in sepsis. Crit Care (2003) 1.11
Management of sepsis. BMJ (2007) 1.08
Metabolomic derangements are associated with mortality in critically ill adult patients. PLoS One (2014) 1.08
The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate. Crit Care (2006) 1.07
Endocrine emergencies in critically ill patients: Challenges in diagnosis and management. Indian J Endocrinol Metab (2012) 1.06
Tissue-specific difference in the molecular mechanisms for the development of acute insulin resistance after injury. Endocrinology (2008) 1.05
Proven infection-related sepsis induces a differential stress response early after ICU admission. Crit Care (2010) 1.03
Hormonal status in protracted critical illness and in-hospital mortality. Crit Care (2011) 1.01
Harvesting, identification and barrier function of human lung microvascular endothelial cells. Vascul Pharmacol (2010) 1.01
Selective histone deacetylase-6 inhibition attenuates stress responses and prevents immune organ atrophy in a lethal septic model. Surgery (2014) 1.00
Corticosteroids influence the mortality and morbidity of acute critical illness. Crit Care (2006) 0.99
Cortisol levels in cerebrospinal fluid correlate with severity and bacterial origin of meningitis. Crit Care (2007) 0.99
Regulation of cortisol bioavailability--effects on hormone measurement and action. Nat Rev Endocrinol (2012) 0.98
Glucocorticoids in sepsis: dissecting facts from fiction. Crit Care (2011) 0.97
Surrogate and patient discrepancy regarding consent for critical care research. Crit Care Med (2012) 0.96
Septic serum induces glucocorticoid resistance and modifies the expression of glucocorticoid isoforms receptors: a prospective cohort study and in vitro experimental assay. Crit Care (2013) 0.95
Treating critical illness: the importance of first doing no harm. PLoS Med (2005) 0.94
Clinical review: Thinking outside the box--an iconoclastic view of current practice. Crit Care (2011) 0.94
Adrenal insufficiency: etiology, diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes (2010) 0.93
Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids. Crit Care (2004) 0.91
Expression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaB. J Cell Mol Med (2007) 0.91
Pituitary-adrenal function in patients with acute subarachnoid haemorrhage: a prospective cohort study. Crit Care (2008) 0.91
What is the rationale for hydrocortisone treatment in children with infection-related adrenal insufficiency and septic shock? Arch Dis Child (2006) 0.89
Update on adrenal insufficiency in patients with liver cirrhosis. World J Gastroenterol (2013) 0.89
Etomidate, adrenal function, and mortality in critically ill patients. Respir Care (2013) 0.88
Etomidate should be used carefully for emergent endotracheal intubation in patients with septic shock. J Korean Med Sci (2008) 0.88
Dengue shock. J Emerg Trauma Shock (2011) 0.87
Critical illness-related corticosteroid insufficiency in patients with severe acute biliary pancreatitis: a prospective cohort study. Crit Care (2009) 0.86
Biomarkers in sepsis. Curr Opin Pulm Med (2013) 0.85
Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated). Crit Care (2005) 0.85
Functional adrenal insufficiency among critically ill patients with human immunodeficiency virus in a resource-limited setting. Afr Health Sci (2007) 0.83
Resistance of LPS-activated bone marrow derived macrophages to apoptosis mediated by dexamethasone. Sci Rep (2014) 0.83
Role of human recombinant activated protein C and low dose corticosteroid therapy in sepsis. Indian J Anaesth (2010) 0.83
Adrenal function testing in patients with septic shock. Crit Care (2006) 0.83
Association of hyperglycemia, glucocorticoids, and insulin use with morbidity and mortality in the pediatric intensive care unit. J Diabetes Sci Technol (2012) 0.82
Prognostic role of copeptin after stroke: A systematic review and meta-analysis of observational studies. Sci Rep (2015) 0.82
Pro-con debate: steroid use in ACTH non-responsive septic shock patients with high baseline cortisol levels. Crit Care (2006) 0.82
Disturbances of the hypothalamic-pituitary-adrenal axis and plasma electrolytes during experimental sepsis. Ann Intensive Care (2011) 0.81
Adrenal insufficiency in patients with stable non-cystic fibrosis bronchiectasis. Indian J Med Res (2014) 0.81
The effects of moderate-dose steroid therapy in sepsis: A placebo-controlled, randomized study. J Res Med Sci (2011) 0.81
The effect of light on critical illness. Crit Care (2011) 0.80
Hypopituitarism in Traumatic Brain Injury-A Critical Note. J Clin Med (2015) 0.80
Changes in CRH and ACTH synthesis during experimental and human septic shock. PLoS One (2011) 0.80
Post-cardiac arrest syndrome: Mechanisms and evaluation of adrenal insufficiency. World J Crit Care Med (2012) 0.80
Plasma cytokine levels predict response to corticosteroids in septic shock. Intensive Care Med (2016) 0.79
Cortisol replacement for severe sepsis and septic shock: what should I do? Crit Care (2002) 0.79
Etomidate and adrenal insufficiency: the controversy continues. Crit Care (2010) 0.79
Should heparin-binding protein levels be routinely monitored in patients with severe sepsis and septic shock? Crit Care (2012) 0.78
The International Sepsis Forum's controversies in sepsis: corticosteroids should be used to treat septic shock. Crit Care (2002) 0.78
Relationship between alcohol use disorders, cortisol concentrations, and cytokine levels in patients with sepsis. Crit Care (2010) 0.78
Prevalence of occult adrenal insufficiency and the prognostic value of a short corticotropin stimulation test in patients with septic shock. Indian J Crit Care Med (2009) 0.78
Serum copeptin and cortisol do not accurately predict sickle cell anaemia vaso-occlusive crisis as C-reactive protein. PLoS One (2013) 0.78
Critical illness-related corticosteroid insufficiency in cancer patients. Support Care Cancer (2011) 0.77
The effect of methylprednisolone on treatment in rats with induced sepsis. Clin Exp Med (2008) 0.77
Hypothalamic-pituitary-adrenal axis in lethal canine Staphylococcus aureus pneumonia. Am J Physiol Endocrinol Metab (2014) 0.77
Treatment of severe sepsis: where next? Current and future treatment approaches after the introduction of drotrecogin alfa. Vasc Health Risk Manag (2006) 0.77
Basal serum cortisol levels are not predictive of response to corticotropin but have prognostic significance in patients with septic shock. J Korean Med Sci (2007) 0.77
Successful treatment with hydrocortisone for heat stroke with critical illness-related corticosteroid insufficiency: transitional changes in serum cytokine and cortisol concentrations. J Anesth (2009) 0.76
Prognostic value of cortisol response in septic shock. JAMA (2000) 0.76
Is hypothyroidism and hypogonadism an issue after aneurysmal subarachnoid hemorrhage-an institutional experience? Int J Endocrinol Metab (2013) 0.76
Inhibition of endogenous glucocorticoid synthesis aggravates lung injury triggered by septic shock in rats. Int J Exp Pathol (2015) 0.76
CORTICUS: the end of unconditional love for steroid use? Crit Care (2009) 0.76
Determining relevant cortisol concentrations in critically ill patients. Crit Care (2010) 0.76
New insights into acute lung injury. Vascul Pharmacol (2010) 0.76
A prospective study on the incidence and predictive factors of relative adrenal insufficiency in Korean critically-ill patients. J Korean Med Sci (2009) 0.76
Roundtable debate: Controversies in the management of the septic patient--desperately seeking consensus. Crit Care (2005) 0.76
Etomidate in sepsis: understanding the dilemma. J Thorac Dis (2015) 0.75
Serum cortisol level and adrenal reserve as a predictor of patients' outcome after successful cardiopulmonary resuscitation. J Cardiovasc Thorac Res (2016) 0.75
Cosyntropin as a diagnostic agent in the screening of patients for adrenocortical insufficiency. Clin Pharmacol (2010) 0.75
Cortisol is an associated-risk factor of brain dysfunction in patients with severe sepsis and septic shock. Biomed Res Int (2014) 0.75
The adrenal gland and corticosteroid therapy in sepsis: I certainly remain uncertain. Crit Care Med (2015) 0.75
Normal adrenocortical function on initial testing in the intensive care unit: not a long-term warranty. Crit Care (2008) 0.75
Cortisol Correlates with Severity of Illness and Poorly Reflects Adrenal Function in Pediatric Acute Respiratory Distress Syndrome. J Pediatr (2016) 0.75
Pro/con clinical debate: are steroids useful in the management of patients with septic shock? Crit Care (2002) 0.75
Final "perspectives on the news": American Association of Clinical Endocrinology and American Diabetes Association 2011. Diabetes Care (2011) 0.75
Endocrine dysfunction following traumatic brain injury: a 5-year follow-up nationwide-based study. Sci Rep (2016) 0.75
Corticosteroids in septic shock: a systematic review and network meta-analysis. Crit Care (2017) 0.75
Serum macrophage migration inhibitory factor reflects adrenal function in the hypothalamo-pituitary-adrenal axis of septic patients: an observational study. BMC Infect Dis (2009) 0.75
Severe sepsis: Low expression of the renin-angiotensin system is associated with poor prognosis. Exp Ther Med (2014) 0.75
Prognostic value of cortisol response in septic shock. JAMA (2000) 0.75
Sepsis-related stress response: known knowns, known unknowns, and unknown unknowns. Crit Care (2010) 0.75
Time-dependent association of glucocorticoids with adverse outcome in community-acquired pneumonia: a 6-year prospective cohort study. Crit Care (2017) 0.75
Relative adrenal insufficiency as a predictor of disease severity and mortality in severe septic shock. Rev Bras Ter Intensiva (2012) 0.75
CAGS and ACS evidence based reviews in surgery. 35: Efficacy and safety of low-dose hydrocortisone therapy in the treatment of septic shock. Can J Surg (2010) 0.75
Endocrinologic Diseases in Pediatric Cardiac Intensive Care. Pediatr Crit Care Med (2016) 0.75
The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock. Crit Care (2002) 0.75
Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet (1989) 3.01
Cardiac variability in critically ill adults: influence of sepsis. Crit Care Med (2001) 1.94
Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study. Am J Transplant (2011) 1.75
Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. Arch Neurol (2001) 1.73
Corticosteroids for treating severe sepsis and septic shock. Cochrane Database Syst Rev (2004) 1.65
Mechanisms underlying effects of nocturnal ventilation on daytime blood gases in neuromuscular diseases. Eur Respir J (1999) 1.55
Comparison of the two-sided single triangular test to the double triangular test. Control Clin Trials (2001) 1.53
Correlation between decreased myocardial glucose phosphorylation and the DNA mutation size in myotonic dystrophy. Circulation (1994) 1.47
Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am J Respir Crit Care Med (1999) 1.46
Lack of effficacy of botulinum toxin in chronic anal fissure. Aliment Pharmacol Ther (2003) 1.44
Circulating transforming growth factor beta 1 (TGF-beta1) in Guillain-Barré syndrome: decreased concentrations in the early course and increase with motor function. J Neurol Neurosurg Psychiatry (1998) 1.41
Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol (1998) 1.34
High-dose intravenous gammaglobulin for myasthenia gravis. Lancet (1984) 1.21
Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev (2006) 1.15
Breathing disorders during sleep in myasthenia gravis. Ann Neurol (1992) 1.15
Sleep-related respiratory disturbances in patients with Duchenne muscular dystrophy. Eur Respir J (1994) 1.09
[Orthostatic hypotension without change in pulse rate. Hemodynamic study of an amyloid neuropathy and of a transitory idiopathic form]. Rev Neurol (Paris) (1971) 1.06
High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function. Intensive Care Med (1995) 1.05
Long-term effects of nasal intermittent positive-pressure ventilation on pulmonary function and sleep architecture in patients with neuromuscular diseases. Chest (1996) 1.01
Accuracy of a composite score using daily SAPS II and LOD scores for predicting hospital mortality in ICU patients hospitalized for more than 72 h. Intensive Care Med (2001) 1.01
Corticosteroids for myasthenia gravis. Cochrane Database Syst Rev (2005) 0.99
Compartmentalised inducible nitric-oxide synthase activity in septic shock. Lancet (2000) 0.97
Comparison of four sequential methods allowing for early stopping of comparative clinical trials. Clin Sci (Lond) (2000) 0.97
Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies. Neurology (2001) 0.96
Methodological issues in pharmacokinetic-pharmacodynamic modelling. Clin Pharmacokinet (1998) 0.96
Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases. Neurology (1983) 0.96
Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis. J Neurol (2000) 0.95
Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method. J Clin Oncol (1996) 0.94
Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev (2004) 0.93
[The Landry-Guillain-Barré syndrome. Study of prognostic factors in 223 cases]. Rev Neurol (Paris) (1986) 0.93
Intravenous gamma-globulin in myasthenia gravis: interaction with anti-acetylcholine receptor autoantibodies. J Clin Immunol (1991) 0.93
Kinetics of elimination and acute consequences of cerebral air embolism. J Neuroimaging (1995) 0.90
Phlegmonous gastritis associated with HIV-1 seroconversion. Endoscopic and microscopic evolution. Dig Dis Sci (1992) 0.89
Limitations of sniff nasal pressure in patients with severe neuromuscular weakness. J Neurol Neurosurg Psychiatry (2003) 0.89
Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis. J Neuroimmunol (1993) 0.88
Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients. J Neurol Neurosurg Psychiatry (2005) 0.88
Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation. Eur Respir J (2002) 0.88
Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders. Cochrane Database Syst Rev (2007) 0.88
Rectal adaptation to distension in patients with overt rectal prolapse. Br J Surg (1998) 0.88
Antireflux surgery for non-erosive and erosive reflux disease in community practice. Aliment Pharmacol Ther (2006) 0.87
Effects of mechanical ventilation with normobaric oxygen therapy on the rate of air removal from cerebral arteries. Crit Care Med (1994) 0.87
[Non-invasive regional and cardiac output determination in healthy volunteers. Predictive value]. Arch Mal Coeur Vaiss (1989) 0.87
Single-dose amoxycillin-clavulanic acid vs. cefotetan for prophylaxis in elective colorectal surgery: a multicentre, prospective, randomized study. The PRODIGE Group. J Hosp Infect (1992) 0.87
Association of herpes simplex virus encephalitis and paraneoplastic encephalitis - a clinico-pathological study. Ann Pathol (2000) 0.86
Analysis of phase II clinical trials in haematology and oncology: comparison of the triangular test to the usual methods. Stat Med (1991) 0.86
Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev (2001) 0.86
Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group. Intensive Care Med (1999) 0.85
Differential effects of two types of antidepressants, amitriptyline and fluoxetine, on anorectal motility and visceral perception. Aliment Pharmacol Ther (2004) 0.85
Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain-Barré syndrome. J Neuroimmunol (1996) 0.85
Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders. Arch Phys Med Rehabil (2001) 0.84
Placebo-controlled, randomized, double-blind study of intravenous enalaprilat efficacy and safety in acute cardiogenic pulmonary edema. Circulation (1996) 0.84
Hemodynamic and histomorphometric characteristics of dilated cardiomyopathy of Syrian hamsters (Bio TO-2 strain). Can J Physiol Pharmacol (2001) 0.84
Long-term results of treatment of childhood acute lymphoblastic leukemia in the Czech Republic. Leukemia (2009) 0.83
Acute carbon monoxide intoxication and hyperbaric oxygen in pregnancy. Intensive Care Med (1991) 0.83
Acute pancreatitis and preeclampsia-eclampsia: a case report. Am J Obstet Gynecol (1997) 0.83
[Treatment of Gram-negative septicaemia with cefotaxime: 16 cases (author's transl)]. Nouv Presse Med (1981) 0.83
Severe community-acquired pneumococcal pneumonia. The French Study Group of Community-Acquired Pneumonia in ICU. Scand J Infect Dis (1995) 0.83
Impaired cerebral glucose metabolism in myotonic dystrophy: a triplet-size dependent phenomenon. Neuromuscul Disord (1998) 0.82
Fecal incontinence with normal anal canal pressures: where is the pitfall? Am J Gastroenterol (1999) 0.82
Pharmacoepidemiological characterisation of zolpidem and zopiclone usage. Eur J Clin Pharmacol (2013) 0.82
Potential danger of thrombosis after plasma exchange in the treatment of patients with immune disease. Transfusion (1980) 0.82
Selective impairment of serum antibody repertoires toward muscle and thymus antigens in patients with seronegative and seropositive myasthenia gravis. Eur J Immunol (1998) 0.82
Involvement of human muscle acetylcholine receptor alpha-subunit gene (CHRNA) in susceptibility to myasthenia gravis. Proc Natl Acad Sci U S A (1994) 0.82
[Iatrogenic air embolism]. Presse Med (1996) 0.82
Intravenous immune globulin versus plasma exchange in Guillain-Barré syndrome. N Engl J Med (1992) 0.82
[Long-term effects of plasma exchange in myasthenia. Results of a randomized study]. Presse Med (1983) 0.82
Association of the gene encoding the delta-subunit of the muscle acetylcholine receptor (CHRND) with acquired autoimmune myasthenia gravis. Genes Immun (2004) 0.81
Immunoglobulin A levels in bronchial samples during mechanical ventilation and onset of nosocomial pneumonia in critically ill patients. Am J Respir Crit Care Med (1996) 0.81
Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barré syndrome. Neurology (1999) 0.81
Perception of and adaptation to rectal isobaric distension in patients with faecal incontinence. Gut (1999) 0.80
Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine. Clin Pharmacol Ther (1999) 0.80
Biological and hemodynamic effects of low doses of fludrocortisone and hydrocortisone, alone or in combination, in healthy volunteers with hypoaldosteronism. Clin Pharmacol Ther (2010) 0.80
Blunted coronary reserve in myotonic dystrophy. An early and gene-related phenomenon. Circulation (1996) 0.79
Association of the AChRalpha-subunit gene (CHRNA), DQA1*0101, and the DR3 haplotype in myasthenia gravis. Evidence for a three-gene disease model in a subgroup of patients. J Autoimmun (1997) 0.79
Inhibition of the adhesion step of leukodiapedesis: a critical event in the recovery of Guillain-Barré syndrome associated with accumulation of proteolytically active lymphocytes in blood. J Neuroimmunol (2001) 0.79
Genetic control of autoantibody expression in autoimmune myasthenia gravis: role of the self-antigen and of HLA-linked loci. Genes Immun (2004) 0.79
Pharmacological strategies in the treatment of cerebral ischemia. Eur Neurol (1995) 0.79
Temporal profile of aminergic neurotransmitter release in striatal dialysates in rats with post-ischemic seizures. Exp Brain Res (1994) 0.78
Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines. Intensive Care Med (1996) 0.78
Effects of cholinergic agents on anorectal physiology. Aliment Pharmacol Ther (1998) 0.78
Arterial vasodilating profile and biological effects of pinacidil in healthy volunteers. Br J Clin Pharmacol (1991) 0.78
Cost analysis of plasma-exchange therapy for the treatment of Guillain-Barré syndrome. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Intensive Care Med (2000) 0.78
Dose-response study of metoclopramide in gastroesophageal reflux in infancy. Fundam Clin Pharmacol (1993) 0.78